US equities |
SPCX $171.09 ▲+0.00% MU $1,063.96 ▲+0.00% NVDA $238.90 ▲+0.00% META $741.90 ▲+0.00% AMD $631.75 ▲+0.00% AMZN $251.40 ▲+0.00% INTC $116.19 ▲+0.00% SNDK $1,704.16 ▲+0.00%
FinancialContent

Articles published by insitro

News headline image
insitro Designed Machine Learning Models for Small Molecule in vivo Pharmacokinetic Behavior Prediction Now Available in Lilly TuneLab
From insitro
Via Business Wire
News headline image
insitro Appoints Hideo Makimura as Chief Medical Officer to Lead Its Transition to a Clinical-Stage Company
From insitro
Via Business Wire
News headline image
insitro Presents New Data Demonstrating Its AI-Discovered MASH Candidate Shows Anti-Fibrotic Signal Beyond Liver-Fat Reduction at the American Diabetes Association 86th Scientific Sessions
From insitro
Via Business Wire
News headline image
insitro and Bristol Myers Squibb Collaboration Expanded with Nomination of New Targets
From insitro
Via Business Wire
News headline image
insitro Appoints Joe Hand as Chief People Officer to Advance Talent Strategy for Next Stage of Development
From insitro
Via Business Wire
News headline image
insitro Completes First AI-Enabled Human Genetics Study of Brown Adipose Tissue, Shares Differentiated Targets with Anti-Obesity Effects
From insitro
Via Business Wire
News headline image
insitro to Acquire CombinAbleAI to Complete its Full Stack, Modality-Agnostic AI Platform for Drug Discovery and Design
From insitro
Via Business Wire
News headline image
insitro to Present at the 44th Annual J.P. Morgan Healthcare Conference
From insitro
Via Business Wire
News headline image
insitro Validates AI-Enabled POSH Platform in Nature Communications, Bridging Critical Gap in Drug Discovery
From insitro
Via Business Wire
News headline image
insitro Appoints R&D Veteran Stephen Hitchcock and AI Visionary Vijay Pande as Scientific Advisors
From insitro
Via Business Wire
News headline image
insitro Extends Research Collaboration with Bristol Myers Squibb Leveraging insitro’s ChemML Discovery Platform
From insitro
Via Business Wire
News headline image
insitro Partners with Lilly to Build First-in-Kind Machine Learning Models to Advance Small Molecule Drug Discovery
From insitro
Via Business Wire
News headline image
insitro and UK’s INSIGHT at Moorfields Eye Hospital Announce Collaboration to Expand Research Efforts in Neurodegeneration and Related Conditions
From insitro
Via Business Wire
News headline image
insitro Receives $25 Million in Milestone Payments from Bristol Myers Squibb for the Achievement of Discovery Milestones and the Selection of First Novel Genetic Target for ALS
From insitro
Via Business Wire
News headline image
insitro and Lilly Enter Strategic Agreements to Advance Novel Treatments for Metabolic Diseases
From insitro
Via Business Wire
News headline image
insitro Hires AI and Machine Learning Visionary, Emily Fox, Ph.D., as Senior Vice President of AI/ML
From insitro
Via Business Wire
News headline image
Leading Clinical Research Innovator, Amy Abernethy, M.D., Ph.D., Joins insitro Board of Directors
From insitro
Via Business Wire
News headline image
insitro Hires Chief Medical Officer to Advance Therapeutic Programs Toward the Clinic
From insitro
Via Business Wire
News headline image
insitro to Present at the 42nd Annual J.P. Morgan Healthcare Conference
From insitro
Via Business Wire
News headline image
insitro Appoints Philip Tagari, Industry-Leading Scientist and Drug Hunter, as Chief Scientific Officer
From insitro
Via Business Wire
News headline image
insitro Announces Formation of Scientific Advisory Board to Support Platform and Pipeline Advancement
From insitro
Via Business Wire
News headline image
insitro Announces Leadership Team Expansion to Support Advancement of Machine Learning Enabled Drug Discovery and Development Efforts
From insitro
Via Business Wire
News headline image
insitro Appoints Tom Stocky as Vice President of Product
From insitro
Via Business Wire